Literature DB >> 18322051

Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.

Carlos Lorenzo1, Subrata D Nath, Anthony J G Hanley, Hanna E Abboud, Steven M Haffner.   

Abstract

BACKGROUND AND OBJECTIVES: Microalbuminuria increases cardiovascular risk and is considered a metabolic disorder. Low glomerular filtration rate is also associated with increased cardiovascular risk, but the relation of low glomerular filtration rate to metabolic disorders is not well understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Designed as a cross-sectional, epidemiologic study, the Insulin Resistance Atherosclerosis Study was conducted in four centers: San Antonio (Texas), San Luis Valley (Colorado), and Oakland and Los Angeles (California). The Modification of Diet in Renal Disease equation was used to classify individuals without diabetes and with normoalbuminuria (n = 856; age 40 to 69 yr) by the presence or absence of low glomerular filtration rate (<60 ml/min per 1.73 m(2)). A direct marker of insulin resistance, the insulin sensitivity index, was measured by the frequently sampled intravenous glucose tolerance test.
RESULTS: Low glomerular filtration rate was related to hypertension and the metabolic syndrome. Low glomerular filtration rate was associated with fasting insulin concentration and insulin sensitivity index. Low glomerular filtration rate was also associated with insulin concentration after adjustment for potential determinants of glomerular filtration rate but was not associated with insulin sensitivity index.
CONCLUSIONS: Low glomerular filtration rate is associated with increased insulin concentration in individuals without diabetes and with normoalbuminuria. Longitudinal analyses are needed to determine whether insulin concentration (insulin resistance) precedes the deterioration of renal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322051      PMCID: PMC2386711          DOI: 10.2215/CJN.02730707

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  48 in total

1.  High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells.

Authors:  Meenalakshmi M Mariappan; Denis Feliers; Srinivas Mummidi; Goutam Ghosh Choudhury; Balakuntalam S Kasinath
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

2.  Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure.

Authors:  O Heimbürger; F Lönnqvist; A Danielsson; J Nordenström; P Stenvinkel
Journal:  J Am Soc Nephrol       Date:  1997-09       Impact factor: 10.121

3.  Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests.

Authors:  W Gatling; C Knight; M A Mullee; R D Hill
Journal:  Diabet Med       Date:  1988 May-Jun       Impact factor: 4.359

4.  Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture.

Authors:  C K Abrass; D Spicer; G J Raugi
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

Review 5.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

6.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

Authors:  E M Macy; T E Hayes; R P Tracy
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

7.  The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.

Authors:  L E Wagenknecht; E J Mayer; M Rewers; S Haffner; J Selby; G M Borok; L Henkin; G Howard; P J Savage; M F Saad
Journal:  Ann Epidemiol       Date:  1995-11       Impact factor: 3.797

8.  Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose.

Authors:  M T Korytkowski; S L Berga; M J Horwitz
Journal:  Metabolism       Date:  1995-09       Impact factor: 8.694

9.  A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

Authors:  M F Saad; R L Anderson; A Laws; R M Watanabe; W W Kades; Y D Chen; R E Sands; D Pei; P J Savage; R N Bergman
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

10.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

Authors:  G Pacini; R N Bergman
Journal:  Comput Methods Programs Biomed       Date:  1986-10       Impact factor: 5.428

View more
  8 in total

1.  Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Steven M Haffner
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

2.  The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  C C Lee; C Lorenzo; S M Haffner; L E Wagenknecht; A Festa; M O Goodarzi; D Stefanovski; N C Olson; J M Norris; M J Rewers; A J Hanley
Journal:  Diabetologia       Date:  2012-10-10       Impact factor: 10.122

3.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

4.  Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.

Authors:  J C Russell; S E Kelly; D F Vine; S D Proctor
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

Review 5.  Vascular toxicity of urea, a new "old player" in the pathogenesis of chronic renal failure induced cardiovascular diseases.

Authors:  Ida Giardino; Maria D'Apolito; Michael Brownlee; Angela Bruna Maffione; Anna Laura Colia; Michele Sacco; Pietro Ferrara; Massimo Pettoello-Mantovani
Journal:  Turk Pediatri Ars       Date:  2017-12-01

6.  Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

Authors:  Cristina Mega; Edite Teixeira de Lemos; Helena Vala; Rosa Fernandes; Jorge Oliveira; Filipa Mascarenhas-Melo; Frederico Teixeira; Flávio Reis
Journal:  Exp Diabetes Res       Date:  2011-11-30

Review 7.  Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives.

Authors:  Laetitia Koppe; Mariana Cassani de Oliveira; Denis Fouque
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

8.  Assessment of Plasma Sodium to Potassium Ratio, Renal Function, Markers of Oxidative Stress, Inflammation, and Endothelial Dysfunction in Nigerian Hypertensive Patients.

Authors:  Oloruntoba A Ekun; Folasade Daniel; Philip Adebola; Adeola Ajibare; Oyeronke O Ekun; Oluwafunso O Omogoroye; Oluwafemi S Ilori; Bankole J Oluwasayo; Mary F Oshundun; Sade R Oyegbami
Journal:  Int J Hypertens       Date:  2020-12-07       Impact factor: 2.420

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.